Import Statistics of Mat under NCM Code 3004 Which Brazil Imports from India
View import statistics of mat under NCM Code 3004, which Brazil imports from India. Study market price & market size of mat along with market share of Brazilian companies importing mat from India.
25 Shipments Records (Demo)
3004 
India
India | Date | NCM Code | Product Description | Origin Country | Quantity | Value | Importer Name | Click to view 16 more columns 16 More Columns Available |
|---|---|---|---|---|---|---|---|
| Jan/2019 | 30049039 | - product: aerodini hfa inhaler (white housing) - 100 mcg / dose tb tc aer al doses- x 200 active principle: sulfate salbutamol- batch no. 07641157 (ee80541), manufacturing date: 10/2018, maturity: 10 / 2020- batch no. 07641150 (ee80526) date manufacture: 0 | INDIA | 864,181 | 751,837.47 | ***** | 16 More Columns Available along with Company Name and Other Details etc. |
| Jan/2019 | 30049069 | - finished product: ir pantasun inj 1x40mg / vial - 40 mg / ml powder liof inj vd inc- active ingredient ctfa: basic pantoprazol- cas (chemical abstract services): 102625-70-7- batch no. jkt3635a, production date: 11/04/2018, maturity: 31/10 / 2020.- r | INDIA | 22,304 | 15,166.72 | ***** | |
| Jan/2019 | 30049069 | Zoledronic acid powder for solution injection mglote 4: fabriccao validity of ue802data 09/2018 08 / 2020registro anvisa no. 07/2020 1.5562.0038 maturity | INDIA | 36,040 | 144,160 | ***** | |
| Jan/2019 | 30049069 | Tabs hydrochloride 20 mg paroxetine (3x10); name: paroxetine hydrochloride; active principle: paroxetine hydrochloride; therapeutic class: antidepressants; product registration ms: 1565100050011 maturity 03/2020; pharmaceutical form: tablet r | INDIA | 8,900 | 7,031 | ***** | |
| Jan/2019 | 30049069 | Pantoprazole active ingredient 40 mg 7t: sesquihydrate pantoprazole sodium name: pantoprazole category: log in antiulcer ms: 1006811290071 process: 25351.409021 / 2016-11 maturity: 01/2022 active presentation: 40 mg rev ct with al bl | INDIA | 8,199 | 11,724.57 | ***** | |
| Jan/2019 | 30049079 | - finished product: glimepiride 2mg (3x10t) - 2-mg ct al bl plas inc x 30- active principle: glimepirida- batch no. x17006, manufacture date: 09/2018, maturity: 08 / 2020- registration to product anvisa nr .: 1037006170050, maturity: 02/2020 | INDIA | 4,818 | 1,397.22 | ***** | |
| Jan/2019 | 30049079 | - finished product: glimepiride 2mg (3x10t) - 2-mg ct al bl plas inc x 30- active principle: glimepirida- batch no. x17007, manufacture date: 09/2018, maturity: 08 / 2020- registration to product anvisa nr .: 1037006170050, maturity: 02/2020 | INDIA | 4,875 | 1,413.75 | ***** | |
| Jan/2019 | 30049079 | - finished product: glimepiride 2mg (3x10t) - 2-mg ct al bl plas inc x 30- active principle: glimepirida- batch no. x17009, manufacture date: 09/2018, maturity: 08 / 2020- registration to product anvisa nr .: 1037006170050, maturity: 02/2020 | INDIA | 4,812 | 1,395.48 | ***** | |
| Jan/2019 | 30049079 | - finished product: 75 mg clopidogrel bisulfate (3x10s) box containing: 30 tablets - 75 mg rev ct with al al bl x 30- active principle: base batch of the clopidogrel- bisulfate. yg7518061-a, fabricacao: 12/2018, maturity: 11 / 2020- lot no. | INDIA | 33,733 | 51,982.55 | ***** | |
| Jan/2019 | 30049099 | Linezolid iv infusion (2 mg / ml) 300 ml npvc abg - linezolid | batch: lin / gb / a-2/011 | authorization run: 1.00.497-7 | materia prima for use in single test laboratorial, no commercial value. | INDIA | 20 | 80.10 | ***** |
